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1. Introduction 
Drug eluting coronary stents (DES) have been 
demonstrated in the literature to decrease restenosis 
rate compared to bare-metal stents (BMS). 
However, the anti-proliferative drugs released by 
DES may facilitate distal microcirculatory 
dysfunction, thereby  negatively affecting collateral 
microvessels. Considering the protective effect of 
well-grown collaterals, in the event of stent 
thrombosis, impaired collateral function could 
render the thrombosis much more dangerous (Meier 
et al., 2007; Togni et al., 2005). Besides, the results 
of the SYNTAX study indicate that, in patients with 
complex coronary disease, the need to redo the  
revascularization is higher when patients have been 
first treated with DES, as compared to patients who 
initially undergo coronary artery bypass surgery 
(CABG) (Kappetein et al., 2011).   
In this paper, we present the case of a patient (P) 
affected by three-vessel coronary disease, previous 
DES implantation and in-stent restenosis. Using a 
simulating tool previously developed by our group, 
we are able for the first time to quantify the impact 
of the DES eluted drugs on the coronary 
hydrodynamic parameters of this patient. We 
compare his results with those obtained for a panel 
of 10 patients (with three vessel disease, but no 
stent history) published in Maasrani et al. (2011).  
 
2. Methods 
2.1. Case description  
A 65 years old man with no history of myocardial 
infarction was referred for three-vessel disease. 
Five years before, he had been treated by 
percutaneous coronary revascularization (PCI) with 
deployment of DES within the midportion of the 
left anterior descending artery (LAD) and within 
the first obtuse marginal branch of the left 
circumflex artery (LCx). In mid-2012, the patient 
developed effort chest pain. Coronary angiography 
evidenced chronic total occlusion of the first 
segment of the right coronary artery (RCA), and 
severe intra-stent restenosis at the level of the left 
marginal branch, and critical stenosis of the first 
segment of the LAD. Indication to CABG was 
posed and use of the off-pump technique was 
planned.  
 
2.2 Clinical measurements 
Details about the surgical protocol and the per-
operative clinical measurements can be found in 
Maasrani et al. (2011), and are briefly recalled here. 
A great saphenous vein graft (SVG) was 
anastomosed to the right coronary artery, and the 
pressure distal to the occlusion (Pw) as well as the 
central venous (Pv) and aortic pressures (Pao) were 
measured (0G timepoint). After construction of the 
proximal anastomosis, and with the graft 
functioning, the flow within the graft (QRCAg), as 
well as both Pv and Pao were measured (1G 
timepoint). Subsequently, the LAD and LCx 
branches were revascularized using the two internal 
mammary arteries. The flow within each mammary 
graft (QLADg and QLCxg) was then measured, with 
the SVG clamped (2G timepoint), as well as Pao, Pv, 
and Pw. The 3G timepoint corresponds to the 
measurements when the three grafts are 
functioning: Pao, Pv, QLADg, QLCxg, and QRCAg.  
 
2.3 Simulating tool 
Data were then entered into an analog electrical 
model of the coronary circulation (Fig.1) aimed at 
reproducing these clinical situations (Maasrani et 
al., 2011).  In this model, the small diameter vessels 
like capillaries and collateral vessels are 
represented only by their resistance: RLADc, RLCxc, 
RRCAc, and Rcol (same Rcol in all the collateral 
pathways). They are determined in a patient’s 
specific manner. The input of the model is the 
aortic pressure wave, Pao(t). The Matlab (Simulink) 
simulations allow to predict flow and pressures in 
any branch of the model and for all surgical cases 
(0G, 1G, 2G, 3G). The calculated quantities are 
time-dependent, but we focus on average cardiac 
cycle values. The collected clinical data are also 
average cardiac cycle values.  
 
3. Results and Discussion 
The values of the capillary and collateral  
resistances (in mmHg.s/ml) obtained for Patient P 
are RLADc = 241, RLCxc = 808, RRCAc = 213, and Rcol 
= 2980. They can be compared to the mean values 
obtained for the group of 10 patients studied in 
Maasrani et al. (2011): RLADc = 159 ± 97, RLCxc = 
125 ± 60, RRCAc = 125 ± 88, and Rcol = 521 ± 282. 
All the microvascular resistances of Patient P are 
higher than those of other patients, and especially 
its RLCxc and Rcol are dramatically high. This 
indicates deterioration of the collateral pathways 
and of the microcirculatory coronary beds distal to 
the DES. This observation is confirmed by the 
analysis of the measured and simulated flow rates 
and pressures (Table1). The data of the case (1G) 
are not shown, but they lead to the same 
conclusions as do the results obtained in the other 
cases. It appears from the data of Table1 that all the 
flow rates calculated for Patient P are quite lower 
than those obtained for other patients presenting the 
same pathology. This may be related to the high 
values of the distal capillary resistances obtained 
for Patient P. This is especially noticeable for QLCxg 
and QLCx. It also appears that Patient P has no more 
collateral protection (Qcoli, i=1 to 5 < 1 ml/min, in any 
cases). This is related to the very high collateral 
resistances, and is consistent with the finding of 
low Pw values in the (0G) and (2G) cases.  
Moreover, even after complete  revascularization 
(case (3G)), the total coronary perfusion, Qt (Qt = 
QLAD + QLCx + QRCA ),  remains remarkably low.  
 
4. Conclusions 
The loss of collaterality and the increase in 
microvascular resistances following DES 
implantation expose the patient to a higher risk of 
future ischemic events. These findings unveil a 
complex interplay between mechanical and 
biological factors underlying the clinical 
observations from major clinical trials.  
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Figure 1 Analog electrical model for the coronary 
circulation in patients with severe stenoses on 
LMCA, LAD and LCx, and total occlusion of the 
right artery. The dotted lines represent the grafts. 
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 (0G) (2G) (3G) 
Pao, m 64 
75.3 ± 8.0 
71 
70.3 ±10.8 
71 
72.2±10.1 
Pw, m 22 
41.4±7.5 
23 
39.7±6.6 
NA 
Pv, m 10 
8.2 ± 3.5 
6 
8.3 ± 4.7 
7 
8.1 ± 4.5 
QLADg, m NA 
 
18 
28.3±13.1 
14 
26.6±13.0 
QLCxg, m NA 
 
4 
34.1±18.4 
4 
27.6±13.4 
QRCAg, m NA 
 
NA 
 
18 
43.6±22.8 
QLAD, s 11.1 
28.4±24.1 
16.7 
37.4±24.1 
15.5 
33.6±23.0 
QLCx, s 4.6 
31.3±23.5 
5.7 
41.3±23.0 
4.7 
39.7±28.8 
QRCA, s 2.5 
15.6±9.6 
2.9 
12.8±6.6 
18.0 
44.6±23.2 
QRCAc, s 3.8 
19.3±10.3 
4.8 
20.5±10.3 
18.0 
43.6±22.8 
Qcol1, s 0.8 
5.0±3.2 
1.0 
4.2±2.2 
0.0 
-0.1±0.2 
Qcol3, s 0.8 
5.6±3.3 
1.0 
4.4±2.2 
0.0 
0.1±0.1 
Qcol4, s 0.6 
1.7±3.6 
0.9 
3.9±1.9 
0.0 
-0.4±0.4 
Qcol5, s 0.8 
2.0±2.1 
1.0 
3.9±1.8 
0.0 
-0.4±0.4 
Table 1 Measured (m) and simulated (s) data for 
Patient P. In italic are given the corresponding 
values for the group of 10 patients published in 
Maasrani et al. (2011). Pressures are given in 
mmHg, flow rates in ml/min. QLAD, QLCx, and QRCA 
are the flow rates in the LAD, LCx and RCA 
branches, as shown in Fig.1. Qcol2 is not shown 
because Qcol2 = Qcol1.  NA = not applicable.  
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